
...

By Mandy Taheri
Reporter
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
President-elect Donald Trump's nominee for Health and Human Services (HHS), Robert F. Kennedy Jr., has criticized the reliance on the weight-loss drug Ozempic, raising concerns about government funding for it and advocating for addressing the root causes of obesity in America instead.
What Position Was RFK Jr. Nominated For?
Kennedy Jr., who is a vaccine skeptic, was tapped to head the HHS, which leads America's public health agencies. If confirmed as secretary by the U.S. Senate, Kennedy Jr. would be a member of Trump's Cabinet and advise the president on public health matters.
Read More
Bernie Sanders Defense of Tulsi Gabbard Resurfaces as Critics Sound Alarm4 min read

Republican Senator Says New Reports ‘Could’ Sink Pete Hegseth’s Nomination3 min read

Florida Newspaper Warns Matt Gaetz ‘Must Never Become’ Attorney General4 min read

Kennedy Jr., a former independent candidate in the 2024 presidential election, has pledged to "Make America Healthy Again" borrowing from Trump's campaign slogan, "Make America Great Again" (MAGA). He dropped out of the race in late-August and endorsed Trump's campaign.
Kennedy Jr. has spoken about some public health changes, such as vowing to immediately remove fluoride from drinking water, a major reversal in a decades-long practice that has been praised for drastically reducing cavities and strengthening teeth.
He is on leave as the chair of the anti-vaccine group Children's Health Defense, and has long repeated the debunked claim that childhood vaccines cause autism. He also advocated against COVID-19 vaccines during the pandemic.
What Is Ozempic?
Ozempic and other glucagon-like peptide-1 (GLP-1) receptor analogs, such as Wegovy, are drugs that mimic fullness hormone GLP-1 and have been shown to reduce appetite, slow digestion, help stabilize blood sugar levels and impact metabolism. They can be prescribed for type 2 diabetes and obesity.
CNN medical correspondent Dr. Sanjay Gupta also noted that the drugs "stimulate your pancreas to make insulin, that helps you absorb the calories," as well as slow down digestion.
The drugs have become widely popular, and as of May 2024, the nonprofit organization focused on health policy,KFF, found that around one in eight adults in the U.S. have taken a GLP-1 drug.
"Along with weight loss, people are likely to experience muscle loss, not just fat loss," Gupta said regarding potential side effects of the drugs.

...
What Has RFK Jr. Said About Ozempic?
Kennedy Jr. has been critical of the drug as a weight loss method, saying that it focuses on symptoms of obesity rather than fixing what he classifies as root problems, such as food systems and exercise.
He's also opposed Medicare or Medicaid covering expensive weight-loss drugs. As of now, those drugs are not widely covered by either program, but there's some bipartisan support in Congress to change that.
Newsweek has reached out to Kennedy Jr. via email for comment.
In an October appearance on Fox News' Gutfeld!, Kennedy Jr. raised concerns about the drug's pricing, saying, "We're spending $1,600 a month on this drug, there's a bill right now before congress that will make it available to everybody who is overweight, which is 74 percent of the American population."
He continued: "That alone will cost $3 trillion a year. If we spend about one fifth of that giving good food, three meals a day to every man, woman, and child in our country we can solve the obesity and diabetes epidemic overnight for a tiny fraction of the cost."
Instead of health insurance paying for the drug, Kennedy Jr. said during a late-September town hall in Philadelphia: "If a doctor's patient has diabetes or obesity, the doctor ought to be able to say, I'm going to recommend gym membership, and I'm going to recommend good food, and Medicaid ought to be able to finance those things the same as they would Ozempic."
During his Gutfeld! appearance, Kennedy Jr. also said that the drug's manufacturer, Novo Nordisk, which is based in Denmark, isn't marketing it to Europeans, but instead "they're counting on selling it to Americans because we're so stupid and so addicted to drugs."
Earlier in September, he wrote in an X, formerly Twitter, post, responding to an article about Ozempic, "When I'm working in the next administration, I will address our sick food system—and the corrupt government agencies—to help make our country healthy again. In the meantime perhaps we should consider replanting the kitchen garden before sending more money to Denmark."
View 0 Comments
Submit Correction
View Editorial & AI Guidelines